Production of Prodigiosin Using Tannery Fleshing and Evaluating Its Pharmacological Effects
Figure 5
(a) Cytotoxic activity of the purified prodigiosin produced by Serratia marcescens against human oral cancer (KB), human cervical adeno carcinoma (HeLa), and human laryngeal cancer (HEp2) cell lines. (b) DNA fragmentation studies by prodigiosin. HEp-2 cells, KB cells, and HeLa cells were treated with IC50 concentration of prodigiosin for 48 h. The untreated cell served as control (C). The fragmented DNA was analyzed by agarose gel electrophoresis.
